Innospec Inc.
General ticker "IOSP" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $2.3B (TTM average)
Innospec Inc. does not follow the US Stock Market performance with the rate: -3.9%.
Estimated limits based on current volatility of 1.2%: low 80.26$, high 82.20$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-11-18, amount 0.87$ (Y2.18%)
- Total employees count: 2450 (+2.1%) as of 2024
- US accounted for 56.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Supply chain disruptions, Manufacturing disruptions, Environmental liabilities, Inflation and interest rates
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [85.98$, 122.53$]
- 2025-12-31 to 2026-12-31 estimated range: [88.25$, 125.05$]
Financial Metrics affecting the IOSP estimates:
- Negative: with PPE of 18.7 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 9.64
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.01
- Positive: 2.95 < Industry operating profit margin (median), % of 5.52
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 6.63 < Operating cash flow per share per price, % of 6.72
- Positive: Shareholder equity ratio, % of 69.82 > 64.17
- Positive: 0.07 < Industry earnings per price (median), % of 2.45
- Negative: Industry operating cash flow per share per price (median), % of 4.99 <= 5.42
Short-term IOSP quotes
Long-term IOSP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,963.70MM | $1,948.80MM | $1,845.60MM |
| Operating Expenses | $1,776.40MM | $1,787.20MM | $1,667.70MM |
| Operating Income | $187.30MM | $161.60MM | $177.90MM |
| Non-Operating Income | $-2.70MM | $12.80MM | $-136.70MM |
| Interest Expense | $1.10MM | $0.00MM | $0.00MM |
| R&D Expense | $38.70MM | $41.70MM | $47.80MM |
| Income(Loss) | $184.60MM | $174.40MM | $41.20MM |
| Taxes | $51.60MM | $35.30MM | $5.60MM |
| Profit(Loss)* | $133.00MM | $139.10MM | $35.60MM |
| Stockholders Equity | $1,038.00MM | $1,147.10MM | $1,211.20MM |
| Inventory | $373.10MM | $300.10MM | $301.00MM |
| Assets | $1,603.70MM | $1,707.40MM | $1,734.70MM |
| Operating Cash Flow | $81.70MM | $207.30MM | $184.50MM |
| Capital expenditure | $42.30MM | $62.10MM | $41.40MM |
| Investing Cash Flow | $-42.10MM | $-111.80MM | $-62.00MM |
| Financing Cash Flow | $-33.70MM | $-39.00MM | $-35.30MM |
| Earnings Per Share** | $5.37 | $5.60 | $1.43 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.